BioSpace News Archive

Lyra Therapeutics, Inc., a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases, today announced it has completed a Series C financing which raised $30 million in new funds.

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 28, 2019.

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, presented preclinical results of TNX-801 to potentially prevent smallpox and monkeypox in a poster at the 2020 ASM Biothreats Conference held January 28-30, 2020 in Arlington, Va.

Equillium, Inc. announced that translational data supporting the potential of itolizumab in the treatment of graft-versus-host disease will be presented at the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy and the Center for International Blood & Marrow Transplant Research being held February 19-23, 2020 at the World Center Marriott in Orlando, Florida.

Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced that it has commenced a proposed underwritten public offering of its common stock.

Bioasis Technologies Inc. (“Bioasis” or the “Company”) (OTCQB:BIOAF; TSX.V:BTI), today announced that it has applied for approval from the TSX Venture Exchange

MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, closed its previously announced $17.5 million strategic investment from PTC Therapeutics, Inc. (“PTC”) and Petrichor Healthcare Capital Management (“Petrichor”), with $10.0 million of notes funded by PTC and $7.5 million of notes funded by Petrichor.

eHealth Technologies, HealtheConnections launch new service supporting image sharing for smaller practices

Dr. Pedro Mego and Arise Vascular have opened the Mission Vascular Center of Excellence to bring quality care, cost savings, and convenient services to the area

Healthcare Trust of America, Inc. (NYSE:HTA), the largest dedicated owner and operator of medical office buildings in the United States, announced today that on Thursday, February 13, 2020, after the market closes, HTA will report its financial results for the three months ending December 31, 2019.